Access to Life-Changing Medications: Eliquis Patient Assistance Application by Bristol Myers Squibb
For many individuals, managing a medical condition such as atrial fibrillation, deep vein thrombosis, or pulmonary embolism can be a significant challenge. The high cost of prescription medications can often exacerbate this burden, making it difficult for patients to afford the treatments they need. To address this issue, Bristol Myers Squibb offers the Eliquis Patient Assistance Application, a program designed to provide eligible patients with access to this essential medication at no cost or at a reduced cost.
The Importance of Affordable Medications
The rising costs of prescription medications have become a pressing concern in the healthcare industry. Many patients struggle to afford the treatments they need, which can lead to poor health outcomes, reduced quality of life, and increased mortality rates. By providing affordable access to medications like Eliquis, Bristol Myers Squibb aims to alleviate this burden and ensure that patients receive the care they need.
What is Eliquis?
Eliquis (apixaban) is an anticoagulant medication used to prevent stroke and blood clots in patients with atrial fibrillation, deep vein thrombosis, or pulmonary embolism. It works by inhibiting the production of clotting factors in the blood, reducing the risk of blood clots and strokes. Eliquis is available in tablet form and is typically taken twice daily.
The Eliquis Patient Assistance Application
The Eliquis Patient Assistance Application is a program designed to provide eligible patients with access to Eliquis at no cost or at a reduced cost. To qualify for the program, patients must meet certain eligibility criteria, including:
- Residing in the United States or Puerto Rico
- Having a valid prescription for Eliquis
- Meeting certain income guidelines (detailed below)
- Not having coverage for Eliquis through any government-funded program, such as Medicare or Medicaid
Income Guidelines:
- Patients with an annual household income of $50,000 or less may be eligible for the program
- Patients with an annual household income between $50,001 and $75,000 may be eligible for a reduced-cost program
How to Apply
To apply for the Eliquis Patient Assistance Application, patients can follow these steps:
- Download and complete the application form from the Bristol Myers Squibb website
- Gather required documentation, including proof of income and residency
- Submit the completed application and supporting documentation to Bristol Myers Squibb
Benefits of the Program
The Eliquis Patient Assistance Application offers several benefits to eligible patients, including:
- Access to Eliquis at no cost or at a reduced cost
- Reduced financial burden for patients and their families
- Improved health outcomes and quality of life
- Simplified application process with dedicated support from Bristol Myers Squibb
Additional Resources
In addition to the Eliquis Patient Assistance Application, Bristol Myers Squibb offers several other resources to support patients and healthcare providers, including:
- Eliquis website: provides information on the medication, its benefits, and potential side effects
- Patient support hotline: offers dedicated support and guidance for patients and healthcare providers
- Healthcare provider resources: provides information and tools for healthcare providers to support patient care
Gallery of Patient Assistance Programs
Frequently Asked Questions
What is the Eliquis Patient Assistance Application?
+The Eliquis Patient Assistance Application is a program designed to provide eligible patients with access to Eliquis at no cost or at a reduced cost.
How do I apply for the Eliquis Patient Assistance Application?
+To apply, patients can download and complete the application form from the Bristol Myers Squibb website, gather required documentation, and submit the completed application and supporting documentation to Bristol Myers Squibb.
What are the income guidelines for the Eliquis Patient Assistance Application?
+Patients with an annual household income of $50,000 or less may be eligible for the program, while patients with an annual household income between $50,001 and $75,000 may be eligible for a reduced-cost program.
Conclusion
The Eliquis Patient Assistance Application is a vital resource for patients who are struggling to afford the medication they need. By providing access to Eliquis at no cost or at a reduced cost, Bristol Myers Squibb aims to alleviate the financial burden of prescription medications and improve health outcomes for patients. If you or a loved one is struggling to afford Eliquis, we encourage you to explore the Eliquis Patient Assistance Application and take the first step towards improved health and well-being.